Key result
LMX1A exerts a tumor suppressive role in gastric cancer by upregulating ANGPTL4, which in turn inhibits the expression of the oncogene C-Myc.
Why the study?
Overexpression of LMX1A inhibits tumor growth in gastric cancers, but the underlying mechanisms remained unclear.
p-value: p=<0.01
LMX1A acts as a tumor suppressor in gastric cancer by upregulating ANGPTL4, which in turn inhibits the oncogene C-Myc.
LMX1A-ANGPTL4 link in gastric cancer cells requires functional validation; leaves open mechanistic role and any therapeutic relevance.
Our research group has showed that the LIM homeobox transcription factor 1 alpha (LMX1A) is inactivated in gastric cancers. Overexpression of LMX1A inhibits tumor growth. However, the mechanisms remains unclear. Considering LMX1A as a transcription factor, a comparison of RNA-seq between gastric cancer cells (GCCs) and GCCs with LMX1A overexpressed was performed to identify genes transcriptionally activated by LMX1A. Among the potential LMX1A target genes, angiopoietin-like 4 (ANGPTL4) has been reported to be an important tumor suppressor and thus was selected for further validation and research. Both LMX1A and ANGPTL4 showed downregulated expression in gastric cancer samples. More importantly, the expression of LMX1A is positively correlated with ANGPTL4, without including other family members in gastric cancer cell lines. What's more, knockdown of ANGPTL4 rescued the tumor suppressive phenotype of LMX1A overexpression, which indicated that LMX1A upregulates ANGPTL4 to exert its role. Mechanistically, we found that LMX1A inhibited the expression of the oncogene C-Myc, which is alleviated by ANGPTL4 knockdown. In general, our results showed that LMX1A exerts its tumor suppressive role by activating ANGPTL4 to inhibit C-Myc.
No takes yet. Share an insight, caveat, or question.
Qian et al. (2019) studied Gastric cancer (n=15). LMX1A overexpression and ANGPTL4 knockdown vs. Empty vector and scramble shRNA (shNC) was evaluated on Tumor growth and C-Myc expression (p=<0.01). LMX1A exerts a tumor suppressive role in gastric cancer by upregulating ANGPTL4, which in turn inhibits the expression of the oncogene C-Myc.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: